Pfizer and BioNTech coronavirus vaccine delivers promising immune response in trial

Another coronavirus vaccine candidate has shown promising results in a Phase 1/2 trial conducted in the US. An mRNA experimental drug made by BioNTech, which partnered with Pfizer for the development of the drug, proved it can deliver the neutralizing … Read more…